$GATO
Gatos Silver, Inc.

2023 Q1 Form 10-K Financial Statement

#000110465923034448 Filed on March 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2021 Q4 2021
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.540M $3.690M $21.45M
YoY Change -18.29% 74.06% 176.06%
% of Gross Profit
Research & Development $30.00K $260.0K $1.660M
YoY Change -72.73% -620.0% 110.13%
% of Gross Profit
Depreciation & Amortization $40.00K $40.00K $90.00K
YoY Change 0.0% -102.26% 200.0%
% of Gross Profit
Operating Expenses $5.600M $3.990M $23.19M
YoY Change -19.19% -419.2% 170.28%
Operating Profit
YoY Change
Interest Expense $4.850M $20.03M $42.62M
YoY Change -27.93% -697.91% -297.04%
% of Operating Profit
Other Income/Expense, Net $1.423M $1.590M -$4.738M
YoY Change 24.17% -189.33% -1.7%
Pretax Income $840.0K -$62.73M -$43.44M
YoY Change -20.0% 1516.75% 24.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $835.0K -$62.73M -$43.44M
YoY Change -95.57% 575.24% 7.41%
Net Earnings / Revenue
Basic Earnings Per Share $0.01 -$0.68
Diluted Earnings Per Share $0.01 -$0.90 -$0.68
COMMON SHARES
Basic Shares Outstanding 69.16M 69.13M 63.99M
Diluted Shares Outstanding 69.31M 63.99M

Balance Sheet

Concept 2023 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.90M $6.600M $6.600M
YoY Change 143.4% -95.6% -95.6%
Cash & Equivalents $12.90M $6.616M $6.600M
Short-Term Investments
Other Short-Term Assets $16.37M $3.558M $3.000M
YoY Change 474.25% -8.28% -16.67%
Inventory
Prepaid Expenses $2.359M $2.976M
Receivables
Other Receivables
Total Short-Term Assets $29.94M $11.77M $11.80M
YoY Change 241.58% -92.45% -92.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $352.8M $333.4M $333.4M
YoY Change -7.11% 204.2% 204.2%
Other Assets $50.00K $35.00K $0.00
YoY Change 78.57% -42.62%
Total Long-Term Assets $352.9M $355.3M $333.4M
YoY Change -7.1% 224.05% 204.2%
TOTAL ASSETS
Total Short-Term Assets $29.94M $11.77M $11.80M
Total Long-Term Assets $352.9M $355.3M $333.4M
Total Assets $382.8M $367.1M $345.2M
YoY Change -1.49% 38.32% 30.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $455.0K $196.0K $1.400M
YoY Change 37.88% -65.0% 133.33%
Accrued Expenses $1.404M $623.0K
YoY Change 24.36% -49.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.00M $1.400M $1.400M
YoY Change 823.08% -65.0% -65.0%
LONG-TERM LIABILITIES
Long-Term Debt $8.700M $12.60M $12.60M
YoY Change -31.5%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $8.700M $12.60M $12.60M
YoY Change -31.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.00M $1.400M $1.400M
Total Long-Term Liabilities $8.700M $12.60M $12.60M
Total Liabilities $32.70M $14.00M $14.00M
YoY Change 115.13% 250.0% 250.0%
SHAREHOLDERS EQUITY
Retained Earnings -$197.9M -$190.9M
YoY Change 15.04% 29.46%
Common Stock $117.0K $117.0K
YoY Change 0.0% 8.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $0.00
Shareholders Equity $350.1M $353.1M $331.2M
YoY Change
Total Liabilities & Shareholders Equity $382.8M $367.1M $345.2M
YoY Change -1.49% 38.32% 30.07%

Cashflow Statement

Concept 2023 Q1 2021 Q4 2021
OPERATING ACTIVITIES
Net Income $835.0K -$62.73M -$43.44M
YoY Change -95.57% 575.24% 7.41%
Depreciation, Depletion And Amortization $40.00K $40.00K $90.00K
YoY Change 0.0% -102.26% 200.0%
Cash From Operating Activities -$4.103M -$6.000M -$21.49M
YoY Change 208.03% -7.55% 16.83%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$261.4M
YoY Change -100.0% 2055.32%
Cash From Investing Activities $0.00 $0.00 -$261.4M
YoY Change -100.0% 2055.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $133.1M
YoY Change -17.05%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 200.0K 139.4M
YoY Change -99.87% -19.17%
NET CHANGE
Cash From Operating Activities -4.103M -6.000M -21.49M
Cash From Investing Activities 0.000 0.000 -261.4M
Cash From Financing Activities 0.000 200.0K 139.4M
Net Change In Cash -4.103M -5.800M -143.5M
YoY Change 208.03% -103.93% -201.12%
FREE CASH FLOW
Cash From Operating Activities -$4.103M -$6.000M -$21.49M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63994693
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43655601
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001517006
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.68
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.80
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.13
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.93
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39649
CY2021 dei Entity Registrant Name
EntityRegistrantName
GATOS SILVER, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
925 W Georgia Street, Suite 910
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2021 dei Entity Address Country
EntityAddressCountry
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3L2
CY2021 dei City Area Code
CityAreaCode
604
CY2021 dei Local Phone Number
LocalPhoneNumber
424-0984
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2021 dei Trading Symbol
TradingSymbol
GATO
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
115071927
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69162223
CY2021 dei Auditor Firm
AuditorFirmId
1263
CY2020 dei Auditor Name
AuditorName
KPMG LLP
CY2020 dei Auditor Firm
AuditorFirmId
185
CY2021 dei Auditor Name
AuditorName
Ernst and Young LLP
CY2021 dei Auditor Location
AuditorLocation
Toronto, Canada
CY2020 dei Auditor Location
AuditorLocation
Denver, Colorado
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6616000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150146000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1592000
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1727000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3879000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11766000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
155752000
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
355310000
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
109597000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
61000
CY2021Q4 us-gaap Assets
Assets
367111000
CY2020Q4 us-gaap Assets
Assets
265410000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
4024000
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
12620000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59183076
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
108000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
543829000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
409728000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190861000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147423000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
144589
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1027000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
353085000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
261386000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
367111000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
265410000
CY2021 us-gaap Exploration Expense
ExplorationExpense
1657000
CY2020 us-gaap Exploration Expense
ExplorationExpense
785000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20893000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7765000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
89000
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
30000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
22639000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
8580000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
35883000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-17585000
CY2021 gato Impairment Of Investment In Affiliates
ImpairmentOfInvestmentInAffiliates
51564000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
195000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4843000
CY2021 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
185000
CY2020 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4047000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4738000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000
CY2021 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
-20799000
CY2020 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
-26447000
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-43438000
CY2020 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-35027000
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-5414000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-43438000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-40441000
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.68
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.80
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.13
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.93
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63994693
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43655601
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
149391000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4563000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
155637000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
18984000
CY2020 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
329000
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
61000
CY2020 gato Distribution From Reorganization
DistributionFromReorganization
27179000
CY2020 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
41000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-40441000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
261386000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7140000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
127107000
CY2021 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
1163000
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-273000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-43438000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
353085000
CY2021 us-gaap Profit Loss
ProfitLoss
-43438000
CY2020 us-gaap Profit Loss
ProfitLoss
-40441000
CY2020 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-5414000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
89000
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
30000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7184000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
4368000
CY2021 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
35883000
CY2020 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-17585000
CY2020 gato Debt Conversion Interest Accrued Settled In Cash
DebtConversionInterestAccruedSettledInCash
-3984000
CY2021 gato Impairment Of Investment In Affiliates
ImpairmentOfInvestmentInAffiliates
51564000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
260000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-329000
CY2021 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-134000
CY2020 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
4752000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1196000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2027000
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-321000
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3479000
CY2020 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3453000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21485000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18388000
CY2020 gato Transfer Of Restricted Cash To Cash
TransferOfRestrictedCashToCash
151000
CY2021 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
261439000
CY2020 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
12298000
CY2020 gato Payments To Acquire Interest In Discontinued Operations
PaymentsToAcquireInterestInDiscontinuedOperations
-18000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-261439000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12129000
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15000000
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
13000000
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7277000
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4039000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
133085000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
160436000
CY2021 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
1027000
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-441000
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
260000
CY2020 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
807000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139394000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
172464000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-143530000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
141947000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150146000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9085000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
886000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6616000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150146000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
168000
CY2020 gato Deferred Financing Costs Included In Accounts Payable And Accrued Liabilities
DeferredFinancingCostsIncludedInAccountsPayableAndAccruedLiabilities
1118000
CY2021 gato Director Fess Converted To Deferred Share Units
DirectorFessConvertedToDeferredShareUnits
306000
CY2020 gato Director Fess Converted To Deferred Share Units
DirectorFessConvertedToDeferredShareUnits
61000
CY2020 gato Conversion Of Related Party Accounts Receivable Into Los Gatos Joint Venture Capital Contribution
ConversionOfRelatedPartyAccountsReceivableIntoLosGatosJointVentureCapitalContribution
9448000
CY2020 gato Conversion Of Convertible Notes To Equity
ConversionOfConvertibleNotesToEquity
15000000
CY2020 gato Underwriting Fees Recorded To Deferred Financing Costs
UnderwritingFeesRecordedToDeferredFinancingCosts
-12076000
CY2020 gato Deferred Financing Costs Charged To Equity
DeferredFinancingCostsChargedToEquity
16874000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates are valuation of stock and stock options; valuation allowances for deferred tax assets; and the fair value of financial instruments and investment in affiliates. At the LGJV, significant items subject to such estimates and assumptions include mineral properties, life of mine revenue and cost assumptions, mineral resource conversion rates to mineral reserves; environmental reclamation and closure obligations and valuation allowances for deferred tax assets.</p>
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
575000
CY2020Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
318000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2976000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3560000
CY2021Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
7000
CY2020Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
1000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3879000
CY2021 gato Royalty Payment Percentage
RoyaltyPaymentPercentage
0.01
CY2021 gato Mineral Lease And Concession Payments Made
MineralLeaseAndConcessionPaymentsMade
24000
CY2020 gato Mineral Lease And Concession Payments Made
MineralLeaseAndConcessionPaymentsMade
414000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
196000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
560000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
623000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1240000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
587000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1964000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
260000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
4024000
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
15000000
CY2020Q4 gato Notes Payable Related Parties Accrued Interest
NotesPayableRelatedPartiesAccruedInterest
187000
CY2020Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2712003
CY2020Q4 gato Debt Conversion Interest Accrued Settled In Non Cash Payment
DebtConversionInterestAccruedSettledInNonCashPayment
3984000
CY2020 gato Related Party Receivables Converted Into Capital
RelatedPartyReceivablesConvertedIntoCapital
5850000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 gato Common Stock Number Of Shares Exchanged For Each Share Pursuant To Reorganization
CommonStockNumberOfSharesExchangedForEachSharePursuantToReorganization
0.39406
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8100000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7184000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
4368000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5712000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4548000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4996000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
861000
CY2021Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
13000000
CY2022Q4 gato Line Of Credit Facility Decrease In Maximum Borrowing Capacity
LineOfCreditFacilityDecreaseInMaximumBorrowingCapacity
50000000
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-43438000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-35027000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
8307000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
7356000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1577000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-8368000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-773000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3942000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-8707000
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-9223000
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
2991000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
49000
CY2021 gato Effective Income Tax Rate Reconciliation True Up Subsidiary Tax Rate Amount
EffectiveIncomeTaxRateReconciliationTrueUpSubsidiaryTaxRateAmount
3059000
CY2020 gato Effective Income Tax Rate Reconciliation Current Year Net Operating Loss Utilization Amount
EffectiveIncomeTaxRateReconciliationCurrentYearNetOperatingLossUtilizationAmount
2186000
CY2021 gato Effective Income Tax Rate Reconciliation True Up Joint Venture Amount
EffectiveIncomeTaxRateReconciliationTrueUpJointVentureAmount
15303000
CY2021 gato Effective Income Tax Rate Reconciliation True Up Stock Options Amount
EffectiveIncomeTaxRateReconciliationTrueUpStockOptionsAmount
1025000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-41000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-307000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q4 gato Current Deferred Tax Assets Accrued Compensation
CurrentDeferredTaxAssetsAccruedCompensation
29000
CY2020Q4 gato Current Deferred Tax Assets Accrued Compensation
CurrentDeferredTaxAssetsAccruedCompensation
457000
CY2021Q4 gato Current Deferred Tax Assets Share Based Compensation
CurrentDeferredTaxAssetsShareBasedCompensation
427000
CY2020Q4 gato Current Deferred Tax Assets Share Based Compensation
CurrentDeferredTaxAssetsShareBasedCompensation
218000
CY2021Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
27800000
CY2021Q4 gato Current Deferred Tax Assets Other Accrued Liabilities
CurrentDeferredTaxAssetsOtherAccruedLiabilities
21000
CY2020Q4 gato Current Deferred Tax Assets Other Accrued Liabilities
CurrentDeferredTaxAssetsOtherAccruedLiabilities
26000
CY2021Q4 gato Noncurrent Deferred Tax Assets Mineral Properties
NoncurrentDeferredTaxAssetsMineralProperties
2057000
CY2020Q4 gato Noncurrent Deferred Tax Assets Mineral Properties
NoncurrentDeferredTaxAssetsMineralProperties
2487000
CY2021Q4 gato Noncurrent Deferred Tax Assets Operating Loss Carryforward
NoncurrentDeferredTaxAssetsOperatingLossCarryforward
22340000
CY2020Q4 gato Noncurrent Deferred Tax Assets Operating Loss Carryforward
NoncurrentDeferredTaxAssetsOperatingLossCarryforward
30729000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
14091000
CY2021Q4 gato Noncurrent Deferred Tax Assets Stock Options
NoncurrentDeferredTaxAssetsStockOptions
8399000
CY2020Q4 gato Noncurrent Deferred Tax Assets Stock Options
NoncurrentDeferredTaxAssetsStockOptions
8182000
CY2020Q4 gato Non Current Deferred Tax Assets Loan Fees
NonCurrentDeferredTaxAssetsLoanFees
1303000
CY2021Q4 gato Noncurrent Deferred Tax Assets Other
NoncurrentDeferredTaxAssetsOther
22000
CY2020Q4 gato Noncurrent Deferred Tax Assets Other
NoncurrentDeferredTaxAssetsOther
27000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60262000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
56320000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
833000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1200000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
229000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
276000
CY2021Q4 gato Deferred Tax Liabilities Exploration And Development
DeferredTaxLiabilitiesExplorationAndDevelopment
19000
CY2020Q4 gato Deferred Tax Liabilities Exploration And Development
DeferredTaxLiabilitiesExplorationAndDevelopment
16000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
585000
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
908000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
833000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1200000

Files In Submission

Name View Source Status
0001104659-23-034448-index-headers.html Edgar Link pending
0001104659-23-034448-index.html Edgar Link pending
0001104659-23-034448.txt Edgar Link pending
0001104659-23-034448-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gato-20211231.xsd Edgar Link pending
gato-20211231x10k.htm Edgar Link pending
gato-20211231x10k003.jpg Edgar Link pending
gato-20211231x10k007.jpg Edgar Link pending
gato-20211231xex10d114.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gato-20211231x10k_htm.xml Edgar Link completed
gato-20211231xex10d151.htm Edgar Link pending
gato-20211231xex10d151g001.jpg Edgar Link pending
gato-20211231xex10d151g002.jpg Edgar Link pending
gato-20211231xex10d151g003.jpg Edgar Link pending
gato-20211231xex10d151g004.jpg Edgar Link pending
gato-20211231xex10d151g005.jpg Edgar Link pending
gato-20211231xex10d151g006.jpg Edgar Link pending
gato-20211231xex10d151g007.jpg Edgar Link pending
gato-20211231xex10d151g008.jpg Edgar Link pending
gato-20211231xex10d151g009.jpg Edgar Link pending
gato-20211231xex10d151g010.jpg Edgar Link pending
gato-20211231xex10d152.htm Edgar Link pending
gato-20211231xex10d152g001.jpg Edgar Link pending
gato-20211231xex10d152g002.jpg Edgar Link pending
gato-20211231xex10d152g003.jpg Edgar Link pending
gato-20211231xex10d152g004.jpg Edgar Link pending
gato-20211231xex10d152g005.jpg Edgar Link pending
gato-20211231xex10d152g006.jpg Edgar Link pending
gato-20211231xex10d152g007.jpg Edgar Link pending
gato-20211231xex10d152g008.jpg Edgar Link pending
gato-20211231xex10d152g009.jpg Edgar Link pending
gato-20211231xex10d152g010.jpg Edgar Link pending
gato-20211231xex10d152g011.jpg Edgar Link pending
gato-20211231xex10d152g012.jpg Edgar Link pending
gato-20211231xex10d152g013.jpg Edgar Link pending
gato-20211231xex10d152g014.jpg Edgar Link pending
gato-20211231xex10d152g015.jpg Edgar Link pending
gato-20211231xex10d152g016.jpg Edgar Link pending
gato-20211231xex10d152g017.jpg Edgar Link pending
gato-20211231xex10d152g018.jpg Edgar Link pending
gato-20211231xex10d152g019.jpg Edgar Link pending
gato-20211231xex10d152g020.jpg Edgar Link pending
gato-20211231xex10d152g021.jpg Edgar Link pending
gato-20211231xex10d152g022.jpg Edgar Link pending
gato-20211231xex10d152g023.jpg Edgar Link pending
gato-20211231xex10d152g024.jpg Edgar Link pending
gato-20211231xex10d152g025.jpg Edgar Link pending
gato-20211231xex10d152g026.jpg Edgar Link pending
gato-20211231xex10d152g027.jpg Edgar Link pending
gato-20211231xex10d152g028.jpg Edgar Link pending
gato-20211231xex10d152g029.jpg Edgar Link pending
gato-20211231xex10d152g030.jpg Edgar Link pending
gato-20211231xex10d152g031.jpg Edgar Link pending
gato-20211231xex10d152g032.jpg Edgar Link pending
gato-20211231xex10d152g033.jpg Edgar Link pending
gato-20211231xex10d18.htm Edgar Link pending
gato-20211231xex10d71.htm Edgar Link pending
gato-20211231xex10d86.htm Edgar Link pending
gato-20211231xex10d86001.jpg Edgar Link pending
gato-20211231xex10d86002.jpg Edgar Link pending
gato-20211231xex10d86003.jpg Edgar Link pending
gato-20211231xex21d1.htm Edgar Link pending
gato-20211231xex23d1.htm Edgar Link pending
gato-20211231xex23d2.htm Edgar Link pending
gato-20211231xex31d1.htm Edgar Link pending
gato-20211231xex31d2.htm Edgar Link pending
gato-20211231xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
gato-20211231_def.xml Edgar Link unprocessable
gato-20211231_pre.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gato-20211231_cal.xml Edgar Link unprocessable
gato-20211231_lab.xml Edgar Link unprocessable